{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiflxvwcx6sp3cr7ghk2vwq44i7pru2dz6grf3ahcsiicubutorxi4",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mhnkzl5wckr2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiemspjoezx3wagsvxyola4lpmt3utahdadcwxpy3otkbzmp3rd23m"
    },
    "mimeType": "image/webp",
    "size": 31314
  },
  "path": "/releases/2026/03/260322020250.htm",
  "publishedAt": "2026-03-22T08:03:11.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study found major drops in depression, anxiety, and psychiatric-related hospital visits among users. Even substance use disorders were significantly lower during treatment. Researchers suspect both lifestyle improvements and direct brain effects could be at play.",
  "title": "Weight loss drug Ozempic cuts depression, anxiety, and addiction risk"
}